ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2020 and some content may be unavailable. To unlock all content for 2020, please visit the archives.

Abstract: PO1523

Whole-Exome Sequencing in 97 Families with Renal Ciliopathies Reveals a Causative Mutation in a Known Kidney Disease Gene in 62% and Identifies Potential Novel Causative Genes

Session Information

Category: Genetic Diseases of the Kidneys

  • 1001 Genetic Diseases of the Kidneys: Cystic

Authors

  • Deutsch, Konstantin, Boston Children's Hospital, Department of Medicine, Boston, Massachusetts, United States
  • Klambt, Verena, Boston Children's Hospital, Department of Medicine, Boston, Massachusetts, United States
  • Kitzler, Thomas Michael, Boston Children's Hospital, Department of Medicine, Boston, Massachusetts, United States
  • Jobst-Schwan, Tilman, Boston Children's Hospital, Department of Medicine, Boston, Massachusetts, United States
  • Shril, Shirlee, Boston Children's Hospital, Department of Medicine, Boston, Massachusetts, United States
  • Mane, Shrikant M., Yale University School of Medicine, New Haven, Connecticut, United States
  • Hildebrandt, Friedhelm, Boston Children's Hospital, Department of Medicine, Boston, Massachusetts, United States
Background

Nephronophthisis-related ciliopathies (NPHP-RC) represent the most frequent genetic cause of end-stage renal disease in the first three decades of life. Affected children present with increased echogenicity and/or cysts on renal ultrasound. As mutations in 96 recessive genes have been identified as disease-causing (Kidney Int 95:914, 2019), whole exome sequencing (WES) represents the best approach for the identification of the causative mutation (Nephrol Dial Transplant 31:1802, 2016). In a previous study of consanguineous or familial cases of NPHP, we identified causative mutations in 63% of all patients (Kidney Int 89:468, 2016) by WES.

Methods

To reveal the percentage of causative mutations in NPHP-RC and to identify potential novel disease genes, we evaluated WES data from 97 families with childhood-onset NPHP-RC for causative mutations in 178 monogenic chronic kidney disease genes. Clinical inclusion criteria were increased renal echogenicity or identification of ≥ 2 renal cysts on renal ultrasound.

Results

In 60 out of 97 families (62%), we identified a mutation in a known monogenic kidney disease gene as causative for the phenotype. Out of these, 47 families harboured mutations in one of the known ciliopathy genes. 13 families were diagnosed for a disease that phenocopies NPHP-RC. Amongst these, CAKUT represented the most frequent phenocopy disease (7/13 families), followed by Alport syndrome, metabolic diseases and nephrocalcinosis (2/13 families each). In 10 families, in which a mutation in known disease genes was excluded, we identified a biallelic mutation in a potential novel causative gene candidate.

Conclusion

By whole exome sequencing we identified a disease-causing mutation in 62% of families with a diagnosis of NPHP based on renal ultrasound and identified 10 potential novel causative gene candidates.

Funding

  • NIDDK Support